Home
Ipca Laboratories Ltd Share Price History
Ipca Laboratories Ltd
NSE : 24 Apr, 2025
1445.7-25.2 (-1.7%)
Prev Close
1470.9
Open Price
1470.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
189070
Today's High / Low
1474.2 / 1436.5
52 WK High / Low
1755.9 / 1052.0
Market Price of Ipca Laboratories Ltd
1M
1Y
3Y
5Y
Monitoring Ipca Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 15.42 |
| YoY Gr. | - |
| Net Profit (Cr.) | 195 |
| BVPS | 194.55 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 13.69 |
| Op. Profit Mgn % | 18.03 |
| Net Profit Mgn % | 8.16 |
| Debt to Equity % | 0.37 |
Latest Shareholding
Promoters Holdings Over Time
About Ipca Laboratories Ltd
- Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
- The products of the Company are now sold in over 100 countries across the globe.
- The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries.
Popular Search
FAQs for Ipca Laboratories Ltd Share Price History
What are the key events that typically impact Ipca Laboratories Ltd's share price history?
Key events that impact Ipca Laboratories Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Ipca Laboratories Ltd's share price history?
Stock splits reduce the nominal price of Ipca Laboratories Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Ipca Laboratories Ltd?
Dividends can influence Ipca Laboratories Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Ipca Laboratories Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Ipca Laboratories Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Ipca Laboratories Ltd’s share price history?
To understand Ipca Laboratories Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
